OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - ASSERTIO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 114 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,392,000,000
-27.5%
1,113,351
-25.8%
0.04%
-26.4%
Q3 2019$1,920,000,000–1,500,000–0.05%–
 Download
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AlphaMark Advisors, LLC 37$00.00%
View complete list of ASSERTIO THERAPEUTICS INC shareholders